Progress in Selective Hydrogenation: Reactivity Trends in PdAu Heterogeneous Catalysts & Developing Chiral Building Blocks for New Homogeneous Catalysts by Chinen, Amy
  
 
 
 
Progress in Selective Hydrogenation: Reactivity Trends in PdAu Heterogeneous 
Catalysts & Developing Chiral Building Blocks for New Homogeneous Catalysts 
 
 
 
 
 
 
 
 
A Senior Honors Project Presented to the Faculty of the 
Department of Chemistry, 
University of Hawaiʻi at Mānoa 
 
 
 
 
 
In Partial Fulfillment of the Requirements 
For Bachelor of Science with Honors in 
Chemistry 
 
 
 
 
 
 
By Amy Chinen 
14 April 2017 
 
 
 
 
 
 
 
 
Committee: 
Dr. Matthew Cain, Mentor 
Dr. Craig Jensen 
 i 
 
Acknowledgements 
I would like to thank Dr. Raj Raman and the Center for Biorenewable Chemicals; Dr. James 
Dumesic, Madeline Ball, and the Dumesic Catalysis Group at the University of Wisconsin – 
Madison; Dr. Brant Landers, the Cain Research Group, Dr. Craig Jensen, and especially my 
adviser Dr. Matthew Cain and at the University of Hawaiʻi at Mānoa.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ii 
 
Abstract 
 
Selective hydrogenation is an essential method for converting cheap starting materials into more 
valuable chemical building blocks. Whether regioselectivity or diastereoselectivity is desired, 
catalysts are often employed to aid in this transformation. This work explores possibilities for fine-
tuning both homogeneous and heterogeneous catalysts. Previously, bimetallic PdAu catalysts were 
used to enable the conversion of biologically produced 4-hydroxycoumarin (4HC) to 
pharmaceutically relevant coumarin and dihydroxycoumarin (DHC), but the subtleties of catalyst 
preparation and the effect of Pd loading were not known. Part I focuses on identifying reactivity 
trends resulting from variations in PdAu catalysts. Several PdAu catalysts with varying Pd:Au 
ratios were prepared by controlled surface reactions (CSR) or incipient wetness impregnation 
(IWI). Using high performance liquid chromatography (HPLC) and gas chromatography-mass 
spectrometry (GCMS), we determined the effects of the preparation method and Pd loading on 
reactivity, selectivity, and resistance to deactivation for the selective hydrogenation of 4HC to 
DHC. Part II aims to develop chiral building blocks for C1-symmetric, P-stereogenic ligands that 
will be used in the asymmetric hydrogenation of heavily functionalized substrates. To date, a new 
diastereoselective method of adding RO-H across a P=P double bond was identified and a new 
sterically dominating R group was generated. The results were analyzed by nuclear magnetic 
resonance (NMR) spectroscopy.  
Keywords: selective hydrogenation, heterogeneous catalysis, biorenewable chemicals, 
asymmetric hydrogenation, homogeneous catalysis, P-stereogenic ligands 
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PART I: Reactivity Trends in Selective Hydrogenation of  
4-Hydroxycoumarin with PdAu Catalysts  
Introduction 
The use of fossil fuels has greatly advanced human civilization. Petroleum and petroleum-
based products are employed in the production of energy, polymers, plastics, lubricants, chemicals, 
cosmetics, and pharmaceuticals. However, there are drawbacks to such a heavy reliance on fossil 
fuels. The necessary mining, drilling, and transporting of these sources has had serious negative 
impacts on the environment. In order to continue to advance society, it is imperative to find and 
implement new ways of satisfying our energy and material needs without sacrificing the 
environment. 
 Biomass is an attractive alternative to fossil fuel as it is readily available domestically, 
renewable, and minimally harmful to the environment. Recent research has shown that 
biosynthesis can be used to selectively de-functionalize biomass into useful chemicals including 
4-hydroxycoumarin (4HC).1 In the synthesis of highly oxygenated species, biomass may in fact be 
a more efficient source than fossil fuel.2 Chemical catalysis offers opportunities for further 
upgrading these biorenewable species into fine chemicals and valuable pharmaceutical building 
blocks like dihydroxycoumarin (DHC).1 Heterogeneous catalysis is favored for industrial methods 
due to the ease of separating the catalyst after conversion.3   
 4HC is a fused-ring system used in the synthesis of Warfarin, an anticlotting agent.2 4HC 
can be produced from plant material by polyketide biosynthesis in genetically engineered yeast, 
mold, and fungi.2,4 It can be further upgraded into the valuable chemical intermediates coumarin 
and dihydrocoumarin (DHC) by heterogeneous chemical catalysis (Scheme 1.1).2 Coumarin is 
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used in  anti-inflammatory, anti-allergy, and bronchial dilation drugs, as well as cosmetics and 
laser dyes.2,5 Both coumarin and DHC can be further condensed in the presence of ammonia to 
nitrogen-based heterocyclic compounds, the class of structures upon which many pharmaceutical 
and agrochemical products are constructed.6  
Scheme 1.1. 4HC hydrogenation pathway to coumarin, DHC, and other products 
 
 The ideal catalyst for the conversion of 4HC to DHC (Scheme 1.1) has a long lifetime and 
is highly active and selective for DHC. Previous work has shown supported palladium and 
bimetallic gold-palladium (PdAu) catalysts to be particularly effective at catalyzing this reaction.2 
Bimetallic catalysts with small, highly dispersed particles have the advantage of lowering material 
costs by increasing surface area for substrate adsorption. In addition to containing more active 
sites, metals deposited onto gold nanoparticles may have enhanced reactivity due to differences in 
morphology and surface electronic structure.7 For these reasons, catalysts with palladium 
deposited on gold nanoparticles were selected as the focus of this work. Silica (SiO2) was chosen 
as the support for its high affinity for gold and lack of interaction with palladium, and its functional 
inertness in the presence of 4HC. Monometallic PdSiO2 catalysts were also tested and compared 
with bimetallic PdAu catalysts. 
 Part I of this thesis aims to identify trends in the effect of variations in PdAu catalysts on 
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the conversion of 4HC. This will positively impact society by increasing the feasibility of 
upgrading biosynthetically produced chemicals into fine chemicals and pharmaceuticals, thereby 
reducing reliance on fossil fuels.   
 
Research Objectives 
1. Identify trends in conversion for monometallic and bimetallic catalysts with varying Pd loads at 
the same time scale in hydrogenation of 4HC to DHC 
2. Identify trends in selectivity for monometallic and bimetallic catalysts with varying Pd loads at 
the same conversion in hydrogenation of 4HC to DHC 
3. Determine deactivation rate of catalysts in hydrogenation of 4HC to DHC 
Scheme 1.2. 4HC hydrogenation pathway to coumarin and DHC 
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Methodology 
Synthesis of Monometallic Catalyst 
 A monometallic Pd/SiO2 catalyst with 2 wt% Pd load on silica support was prepared by 
incipient wetness impregnation (IWI).
  Prior to impregnation, the silica was acid washed by 
treatment with 750 mL of deionized water and 5 mL of 0.1 M solution of HNO3 (aq) at room 
temperature for 1 h. The mixture was filtered and dried in air at 100 °C. An aqueous solution of 
Pd(NO3)2 (10 wt% Pd, 0.879 g, 5.22 mmol) was then added dropwise to the silica under manual 
stirring. The Pd-impregnated support was dried in an oven at 383 K overnight. The resulting solid 
was reduced under H2 at 773 K for 45 min then passivated with 1% O2 in Ar for 0.5 h at room 
temperature to afford the catalyst. 
Synthesis of Bimetallic Catalysts 
 Several AuPd bimetallic catalysts with Pd loading ranging from 0.07 to 0.87 wt% (as 
determined by ICP) on silica support were synthesized. To deposit small, highly dispersed gold 
nanoparticles on the support material, monometallic Au/SiO2 was first produced by deposition 
precipitation in the manner described by Li.8 Acid washed silica (5 g) was added to ~200 mL 
deionized water and stirred for 0.5 h at room temperature. Meanwhile a solution of 0.2 M HAuCl4 
was prepared by treatment of an aqueous solution of HAuCl4 aqueous solution (0.604 g, 1.78 mmol 
HAuCl4) with 9 mL deionized water and added to the silica slurry. A 0.1 M solution of NaOH was 
added to the suspension to achieve pH 9 and the mixture was stirred for 6 h, keeping the pH 
constant. The mixture was then filtered and washed with deionized water. The resulting solid was 
dried in air at 383 K overnight and then reduced in flowing H2 at 623 K. Pd was then deposited 
onto the gold by controlled surface reactions (CSR) as delineated by C. Sener.9 Briefly, the 
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Au/SiO2 produced by deposition precipitation was reduced in a Schlenk tube under H2 at 623 K, 
sealed, and placed in a glove box under Ar. Also in the glove box, Pd was suspended in n-pentane 
to give the desired loading. The Schlenk tube was unsealed, and the Pd solution added. This 
mixture was stirred for 1 h. The Schlenk tube was removed from the glove box and remaining 
solvent was evaporated under vacuum. The sample was reduced under H2 at 773 K for 45 min then 
passivated with 1% O2 in Ar for 0.5 h at room temperature to afford the catalyst. 
Characterization of Catalysts 
 Catalysts were analyzed to determine wt% Au, wt% Pd, Au:Pd, average particle size, and 
dispersion. Weight percents (wt%) of Au and Pd were determined by inductively-coupled plasma 
mass spectrometry (Perkin-Elmer 400 ICP Emission Spectrometer). Particle size and distribution 
of PdAu catalysts were determined by transmission electron microscope (FEI Titan STEM with 
Cs probe aberration corrector at 200 kV with spatial resolution < 0.1 nm) and energy dispersive 
X-ray spectroscopy (EDS).  
Reaction Method 
 The reaction method for hydrogenation of 4HC to DHC was based on the work of 
Schwartz.2 The catalyst, a magnetic stir bar, and feed solution were loaded into a Hastelloy 
pressure vessels (Parr Instruments, Model 3010). The feed consisted of 2 wt% 4HC dissolved in 
tetrahydrofuran (THF). The vessel was sealed and purged with argon, then pressurized to 30 bar 
(30 atm) with H2. The reactions were carried out at 348 K under 30 bar of H2 and stirred at 500 
rpm in a multireactor stirrer system (Parr Instruments, Model 5000). 
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I. Conversion 
 Each catalyst was subjected to the above reaction method for 6 h. The products of each 
reaction (4HDHC, coumarin, DHC, and overhydrogenated products) were compared and analyzed 
by high performance liquid chromatography (HPLC) to evaluate any trends in conversion. (See 
Analysis section below.) Trends based on Pd loading and differences in conversion between 
monometallic and bimetallic catalysts were of particular interest. 
II. Selectivity 
 Once a relationship was identified between Pd loading, duration of reaction, and 
conversion, the resulting curve was used to calculate the catalyst to feed ratio and reaction duration 
required to bring reactions to 5% conversion using each of the catalysts in order to assess the 
selectivity at the early stage. The products at 5% conversion were analyzed by HPLC to determine 
the differences in selectivity between monometallic and bimetallic catalysts. 
III. Deactivation 
 A final aspect of the catalytic reaction we wanted to explore was deactivation. Each catalyst 
was deployed in the standard reaction method for a duration of four hours. Following this reaction, 
a sample of the resulting solution was taken for HPLC to determine conversion and selectivity. 
The remaining solution was filtered, washed with THF, and dried overnight in a 313 K oven. The 
reaction was then repeated with an equal catalyst to feed ratio for the amount of recovered catalyst. 
This process was repeated until three reactions had been carried out with the same catalyst.   
Analysis of Reaction Results 
 The primary method of analysis was reverse-phase HPLC (Waters Alliance 2695 system 
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with Waters 996 UV detector and reverse-phase Agilent Zorbax SB-C18 column (4.6mm × 300 
mm, 5 μm), using 5 mM H2SO4 as the aqueous phase and acetonitrile as the organic modifier). 
Samples of feed and postreaction fluid were filtered through 0.22 μm syringe filters before 
injection. All samples were taken in triplicate, and the results averaged to give a robust value with 
associated standard deviation. In order to identify the peaks and determine product concentration, 
standards of known identity and concentration were produced and injected in the HPLC to produce 
calibration curves. 
 The identities of the products were verified using HPLC fraction collection and gas 
chromatography/mass spectrometry (Shimadzu GCMS-QP2010 with flame ionization detector 
(FID) and DB-5MS capillary column). As products (fractions) eluted from the HPLC column they 
were collected in test tubes. Samples of each fraction were then analyzed by GC/MS and the 
spectra compared against the NIST Standard Reference Database 1A v14. 
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Results & Discussion 
Catalysts 
 Five bimetallic PdAu catalysts were synthesized by deposition precipitation followed by 
CSR. The Au:Pd ratios were determined by EDS and wt% Pd by ICP. The results are presented in 
Table 1.1. One monometallic Pd/SiO2 catalyst was also synthesized with 2 wt% Pd.  
Table 1.1. Analysis of PdAu catalysts 
Catalyst # Theoretical Au:Pd EDS Au:Pd ICP wt% Pd 
15 1:0.15 1:0.15 0.24 
16 1:0.06 1:0.18 0.07 
17 1:0.30 1:0.13 0.39 
19 1:0.30 1:0.07 0.54 
20 1:0.45 1:0.21 0.87 
 
 TEM images confirmed that small, highly dispersed particles were produced (Figures 1.1 
and 1.2). 
Figure 1.1. TEM image of Catalyst #15   Figure 2.1. TEM image of catalyst #16 
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Conversion 
 Reaction Method I was used to investigate the overall conversion of 4HC to 4HDHC, 
coumarin, and DHC by each of the six catalysts on the same timescale (Table 1.2). Conversion 
percentage was determined by HPLC and product identities were confirmed by GC/MS.  
Table 1.2. Pd loading and conversion from 4HC 
Entry Catalyst # Material wt% Pd % Conversion 
1 16 PdAu/SiO2 0.07 0.20 
2 15 PdAu/SiO2 0.24 2.50 
3 17 PdAu/SiO2 0.39 4.73 
4 19 PdAu/SiO2 0.54 9.70 
5 20 PdAu/SiO2 0.87 17.90 
6 99 Pd/SiO2 2.0 5.0 
 
A clear trend can be identified between Pd loading and % conversion. In the case of PdAu 
catalysts, increasing the Pd loading increased conversion for all catalysts. The monometallic 
catalyst (Entry 6) had the highest wt% Pd, but its overall conversion was similar to that of the 
PdAu catalyst with one-fifth the Pd loading (Entry 3). This suggests that bimetallic PdAu catalysts 
of higher Pd loading led to increased activity. Figure 1.3 illustrates the trend. 
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Figure 1.3. Pd loading and conversion chart 
 
Selectivity 
 Reaction Method II was used to determine the selectivity of the catalysts at the same 
percent conversion. Four catalytic reactions were halted at the target conversion of approximately 
five percent and their selectivity was analyzed by HPLC. The results are summarized in Table 1.3. 
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Table 1.3. Selectivity at similar conversion 
Catalyst # wt% Pd % Conversion 4HDHC coumarin DHC over- 
hydrogenated 
17 0.39 4.7 53.2 2.0 44.2 0.6 
19 0.54 5.5 59.6 3.0 34.9 2.5 
20 0.87 5.6 59.3 0.7 37.8 2.2 
99 2.0 5.0 64.7 0.4 31.3 3.6 
 
 Among the catalysts tested, there is a similar distribution of products at the same 
conversion. A slight trend emerges that higher Pd loading increases overhydrogenated products 
and 4HDHC and decreases DHC and coumarin (Figure 1.4). 
       Figure 1.4. Selectivity at 5% conversion 
 
 A closer look at the distribution of the minor products, coumarin and overhydrogenated 
products, shows an effect on the catalysts’ selectivity for these products that may be associated 
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and selectivity for coumarin decreased. 
Figure 1.5. Coumarin and overhydrogenated product selectivity 
 
 
Deactivation 
 Reaction Method III was used to investigate the rate and degree to which two catalysts, 
#19 (PdAu/SiO2) and #99 (Pd/SiO2), deactivated with continued use over time. These catalysts 
were selected for the purpose of comparing the deactivation of monometallic and bimetallic 
catalysts.  
 The results were mixed (Figure 1.6). Both catalysts decreased in effectiveness after the first 
cycle, but the results show increased conversion in the third cycle. In the case of the monometallic 
Pd catalyst, conversion in the third cycle actually appears higher than in the first cycle. This may 
be the result of error or decomposition into an unidentified catalyst species, potentially 
nanoparticles. However from these results we can infer that some deactivation does occur with use 
in both catalysts, and that neither deactivates completely after three four-hour reaction cycles. 
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Figure 1.6. Deactivation of catalysts over three reaction cycles 
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Conclusions & Future Work 
This study has identified trends in the palladium-catalyzed hydrogenation of 4HC based on 
the composition of the heterogeneous catalyst. Bimetallic PdAu/SiO2 catalysts with Pd loading 
ranging from 0.07 to 0.87% were investigated, and catalysts with high loadings demonstrated 
increased conversion of 4HC to its hydrogenated products. There is likely an upper limit to the 
amount of Pd that can be deposited on the catalyst before the active sites become crowded and 
conversion diminishes with increasing Pd loading due to dendritic effects.10 Further research is 
needed to determine this limit. The number of active sites may also be determined by 
chemisorption, which would give more insight into the relationship between Pd loading and 
catalytic activity than merely comparing wt% Pd as was done in this study. It is important to 
optimize the loading to balance cost and effectiveness. 
The bimetallic PdAu/SiO2 catalysts significantly outperformed the monometallic Pd 
catalyst in overall conversion. The addition of gold to the catalyst led to a factor of five increase 
in conversion versus Pd/SiO2. This is important because catalytic materials are expensive, so 
increasing their effectiveness means reducing the cost of these reactions and increasing feasibility. 
At 5% conversion, some selectivity trends were observed. Higher Pd loadings increased 
4HDHC and overhydrogenation and decreased DHC and coumarin products. This trend included 
the monometallic and bimetallic catalysts without distinction. Overhydrogenated products are 
undesirable because retaining the aromatic ring is necessary for the target products. It will be 
important in an industrial setting to balance the benefit of increased overall conversion with high 
Pd loading with the concomitant effect of higher undesired products. 
Finally, it was difficult to gauge the rate and degree of catalyst deactivation in the batch 
   
  
 
 
15 
 
reactor. Activity appeared to decrease in the second cycle then increase in the third; an unlikely 
scenario. It is possible that the catalyst was not rinsed well enough between the second and third 
cycles and some product was transferred to the subsequent experiment, skewing the results. 
Coperét has also attributed increased activity over multiple cycles to breakdown of catalysts into 
nanoparticles, increasing surface area.11 A better way to investigate the cause and extent of 
deactivation would be with a flow reactor. 
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PART II: Developing Chiral Building Blocks for C1-Symmetric,  
P-stereogenic Ligands 
Introduction 
The discovery of teratogenic effects resulting from one enantiomer of the sedative 
thalidomide in the early 1960s demonstrated the importance of enantioselective synthesis in 
pharmaceutical production. Launched as the racemate in 1957, thalidomide was withdrawn from 
the market in 1961 when its use had caused malformation in more than 10,000 children born to 
mothers who used the drug in the first trimester of pregnancy.1 It was discovered that one 
enantiomer had the desired therapeutic effect, while the other caused fetal abnormalities.  
Asymmetric hydrogenation is an important method of generating stereogenic centers in 
pharmaceuticals.2 At present, most asymmetric reactions in the pharmaceutical industry utilize a 
combination of alkenes, which are activated or feature directing groups and privileged C2-
symmetric scaffolds such as BINAP, DuPhos, and DiPAMP (Figure 2.1).3 Despite this success, a 
major gap exists in the design of new ligands and catalysts capable of hydrogenating more densely 
substituted “problem substrates,” such as α,β unsaturated nitriles, substituted quinolines, imines, 
and highly substituted olefins.4  
Figure 2.1. Typical substrates, ligands, and binding pocket  
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The Cain group has hypothesized that C1-symmetric, P-stereogenic ligands constructed 
from prochiral phosphaalkenes may remedy this issue and enable highly selective asymmetric 
hydrogenation of “problem substrates”.5,6 These ligands feature sterically dominating P-
stereocenters to maximize enantioselectivity and a modular and tunable second donor group to 
customize the binding pocket from severely sterically crowded to largely open (Figure 2.2). These 
features permit the optimization of the asymmetric environment for each substrate tested.  
        Figure 2.2. Tunable binding pocket 
 
There are two approaches to constructing the target ligands: 1) chiral building block to 
chiral ligand, and 2) prochiral phosphaalkenes ligand to chiral ligand (Scheme 2.1). 
Scheme 2.1. Two approaches to C1-symmetric, P-chiral ligands 
 
To construct chiral phosphine ligands via Approach 1, the phosphaalkene lone pair is 
coordinated with a simple Lewis acid such as K+, promoting nucleophilic attack at phosphorus and 
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generating a stereocenter.7 Utilizing the mentholate anion as the nucleophile results in phosphinite 
diastereomers; resolution followed by stereoselective P-O bond cleavage affords enantiomerically 
pure C1-symmetric, P-stereogenic ligands (Scheme 2.1, top).
8 The second approach involves 
converting pre-constructed phosphaalkene-derived multidentate ligands into P-stereogenic 
compounds via chiral alcohol addition (Scheme 2.1, bottom).9  
 
Research Objective 
Develop chiral building blocks and prochiral phosphaalkene ligands for use in C1-symmetric, P-
stereogenic ligands 
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Methodology 
Reactions were conducted using anhydrous solvents under an inert atmosphere of nitrogen 
unless otherwise stated. Thin-layer chromatography (TLC) was performed using Sigma-Aldrich 
silica gel precoated glass plates and visualized under ultraviolet light (254 nm). Column 
chromatography was carried out using Fischer 230-400 mesh silica gel. 1H and 31P{1H} NMR 
spectra were recorded using an Agilent DD2 spectrometer at 300 MHz. 1H NMR chemical shifts 
are reported relative to CDCl3 signals and data is reported as follows: chemical shift (δ ppm), 
multiplicity, coupling constant (Hz), and integration. All chemicals were used as received except 
1 and 4 which were synthesized by Dr. Brant Landers. 
Product 3  
Scheme 2.2. Synthetic pathway to 3 
 
In a dry glove box under an inert atmosphere of N2, a suspension of zinc dust (0.05 g, 0.001 
mmol, 1.0 equiv) and HMTPCl2 (0.33 g, 0.001 mmol, 1.0 equiv) in 5 mL of benzene was treated 
with PMe3 (0.15 g, 0.002 mmol, 2.5 equiv) and stirred for 1 h. In a separate vial, a solution of (-)-
menthol (0.15 g, 0.001 mmol, 1.2 equiv) in 5 mL of benzene was transferred to a Schlenk flask 
fitted with a fritted filter and the HMTPCl2 mixture was filtered under vacuum into the 
homogeneous solution. The filter and vial were rinsed with benzene (5 mL) and the Schlenk flask 
sealed. The mixture was stirred for 24 h to afford crude product 2 as an oil (dr = 70:30): 31P NMR 
(121 MHz, CDCl3) δ 80.80 (dd, J = 199, 13 Hz), 73.09 (dd, J = 195, 10 Hz) The mixture containing 
2 was filtered under nitrogen into a second Schlenk flask and the flask and filter rinsed with THF 
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(5 mL). The solution was concentrated under vacuum and the resulting solid dissolved in THF (5 
mL). The flask was removed from the glove box. In a fume hood, BH3 in THF (1.0 M, 4.7 mL, 
0.005 mmol, 6 equiv) was added dropwise via syringe to the flask and the resulting solution stirred 
1 h. The reaction was quenched with H2O. The solution was transferred to a separatory funnel and 
the aqueous layer extracted with DCM (3 × 10 mL). The combined organic layers were dried over 
MgSO4, filtered through Celite, and the filtrate was concentrated under vacuum affording a crude 
solid. Thin layer chromatography (TLC) analysis (90:10 hexanes/EtOAc) indicated the presence 
of both diastereomers of product 3 (dr = 65:35): 31P NMR (121 MHz, CDCl3) δ 86.7 (br), 77.6 
(br). 
Product 6 
Scheme 2.3. Synthetic pathway to 6 
 
In a glove box under N2, zinc dust (0.02g, 0.29 mmol, 1.0 equiv) and THF (2 mL) was 
added to a vial containing 4 (0.10 g, 0.29 mmol, 1.0 equiv) and treated with PMe3 (0.05 g, 0.72 
mmol, 2.5 equiv) in benzene and stirred for 1 h. The resulting mixture was transferred to a Schlenk 
flask and (-)-menthol (0.09 g, 0.58 mmol, 1.2 equiv) was added. The flask was removed from the 
glove box and stirred for 4 h in a fume hood. The solution was concentrated under vacuum to 
afford product 6. 31P NMR (121 MHz, CDCl3) δ 71.06 (dd, J1PH = 210.6, 7.9 Hz), 67.43 (dd, J = 
67, 9 Hz). 
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Phospha-Wittig reaction to product 10 
Scheme 2.4. Phospha-Wittig reaction 
 
In a glove box under N2, a mixture of 4 (2.0 g, 5.76 mmol, 1.0 equiv) and zinc dust (1.0 g, 
5.76 mmol, 1.0 equiv) was treated with a solution of PMe3 (1.1 g, 14.40 mmol, 2.5 equiv) in 2 mL 
THF for 1 h. 2-Pyridinecarboxaldehyde (0.6 g, 5.47 mmol, 0.95 equiv) was added, the flask was 
sealed under N2 and stirred for 4 h in a fume hood. The solution was concentrated under vacuum 
to yield a mixture of 8 and 9 and returned to the glove box. The mixture of 8 and 9 was dissolved 
in pentane and filtered through Celite to remove 9. The resulting solution was concentrated under 
vacuum to yield purified product 8 (1.1 g, 2.99 mmol, 55% yield). 31P NMR (121 MHz, THF): δ 
284. 
Scheme 2.5. (R)-BINOL addition to phospha-Wittig product 
 
Pyridine-phosphaalkene 8 (1.1 g, 2.99 mmol, 1.0 equiv) was transferred to a Schlenk bomb 
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and (R)-BINOL (0.9 g, 3.29 mmol, 1.1 equiv) was added. The mixture was dissolved in DCM (20 
mL) & potassium tert-butoxide (KOtBu) (0.03 g, 0.30 mmol, 10 mol%) was added. The Schlenk 
bomb was sealed and removed from the glove box to an ice bath in a fume hood. The reaction 
mixture was stirred for 6 h then concentrated under vacuum to afford 10 as a solid (dr = 2:1): 31P 
NMR (121 MHz, THF): δ 118, 116. 1H NMR spectrum was also recorded but was difficult to 
interpret due to the presence of both diastereomers and overlap of the aryl regions. 
(2,4,6-Tricyclohexylphenyl)phosphonous dichloride 13  
Scheme 2.6. Alkylation and bromination of benzene, substitution to 13 
 
              11         12                     13 
In a fume hood under N2, a three-necked round bottom flask containing a magnetic stir bar 
and AlCl3 (38 g, 285 mmol) was placed in an ice bath. Benzene (8 mL) and DCM (60 mL) were 
added dropwise via dropping funnel while stirring. Cyclohexyl bromide (35 mL, 487 mmol, 3.0 
equiv) was added via syringe to the dropping funnel and added dropwise to the flask and the 
resulting mixture stirred for 2 h. The reaction was quenched slowly with ice (50 mL), and ether 
(200 mL) was added. The mixture was transferred to a separatory funnel and washed with water 
(2 × 50 mL) and brine (50 mL). The organic layer was dried over MgSO4, filtered, and the filtrate 
was concentrated under vacuum. The product was purified by column chromatography in silica 
gel with hexane as the solvent. The first fraction was collected and concentrated under vacuum to 
afford 11 (24.36 g, 75.06 mmol, 46% yield). The flask containing 11 was transferred to a glove 
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box and dissolved in 15 mL of CHCl3. Br2 (3.6 mL, 70.2 mmol, 1.0 equiv) was added at 0°C over 
the course of 15 min via a dropping funnel. The funnel was rinsed with CHCl3 (5 mL) and the rinse 
was added to the flask. The flask was removed from the ice bath and stirred 2 h, venting 
periodically with N2. The resulting solution was diluted with DCM (50 mL) and washed with H2O 
(100 mL). The mixture was transferred to a separatory funnel, the aqueous layer extracted with 
DCM (3 × 50 mL), and the combined organic layers were washed with NaOH (10 wt%, 50 mL) 
and brine (50 mL). The organic fraction was dried over MgSO4 and filtered into a round-bottom 
flask and concentrated under vacuum. The product was purified by column chromatography in 
silica gel with hexane and then DCM as the eluents. The first fraction was collected and 
concentrated under vacuum until dry. The resulting solid was titrated with EtOAc and stirred for 
20 min. The solution was filtered and washed with EtOAc (25 mL) then dried under vacuum to 
give product 12 (12.433 g, 30.8 mmol, 44% yield): 1H NMR (C6D6): δ 1.35 (s, 9H), 1.58 (s, 18H), 
7.42 (s, 2H) The following procedure was adapted from a method developed by Cowley.10 A 
solution of 12 (12.433 g, 30.8 mmol, 1.0 equiv) in THF (120 mL) was placed in a Schlenk flask, 
cooled to -78°C, and treated with BuLi in hexanes (1.6 M, 21.2 mL, 33.9 mmol, 1.1 equiv) and the 
mixture was stirred for 2 h at -78°C to generate the lithiated product as an oil. PCl3 (2.9 mL, 33.9 
mmol, 1.1 equiv) was placed in a second Schlenk flask cooled to -78°C. The solution containing 
the lithiated product was transferred quantitatively via cannula into the second flask over 30 min, 
maintaining both flasks at -78°C. The product mixture was warmed to room temperature and 
stirred for 2h, then concentrated under vacuum and transferred to the glove box. Pentane (5 mL) 
was added and the resulting mixture was filtered through Celite into a filter flask and rinsed with 
more pentane (5 mL). The resulting solid was dissolved in ether (5 mL) and filtered again. The 
solution was concentrated under vacuum to afford the crude product 13. 1H NMR (300 MHz, 
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CDCl3) δ 7.08 (d, J = 3.4 Hz, 2H), 2.5 (m, 2 H), 2.09-1.72 (m, 8H), 1.61-1.20 (m, 18H) 
Results & Discussion 
 A simple two-step procedure (Scheme 2.2) involving the reduction of HMTPCl2 with zinc 
dust, followed by treating with PMe3 and exposure to (-)-menthol with protection from BH3 
produced 3. Once resolved, this product will be a useful building block to new chiral phosphine 
ligands. This HMT derivative represents an alternative pathway to chiral building blocks, which 
may not be isolable or resolvable via the traditional Mes* route.  
 Secondary phosphinite 6 was also accessed via related chemistry. However, initial 
investigations by Dr. Landers into the feasibility of a second approach using (-)-menthol as the 
chiral group yielded an oily product which did not effectively recrystallize. We attempted to solve 
this problem by using (R)-BINOL as the chiral element in the synthesis of 10. (R)-BINOL features 
axial chirality and possible use as a pincer ligand when incorporated into the pyridine-
phosphaalkene scaffold. Synthesis and purification of 8 from 9 (Scheme 2.4) was accomplished in 
55% yield. Diastereoselective addition of (R)-BINOL (Scheme 2.5) afforded 10 with a dr of 2:1. 
Resolution efforts are ongoing.  
New Phosphaalkene R Groups 
Initial investigations indicated a limitation in the phospha-Wittig approach if the R group 
in RP=PMe3 is not sufficiently large (R ≥ Mes*, Mes* = 2,4,6-tri-tert-butylphenyl).11 Coordination 
of smaller R groups led to oligomerization of target molecules. We were curious if new sterically-
demanding P-R substituents could be developed. 
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Figure 2.3. Sterically bulky R groups 
  
 Synthesis of 13 (Scheme 2.6) was undertaken to investigate whether an additional group, 
tricyclohexylbenzene was sufficiently bulky to prevent undesirable oligomerization. It was hoped 
that a solid product could be obtained and the product purified by recrystallization; however, the 
product was oily and separation was not achieved despite several attempts.  
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Conclusions and Future Work 
 This study has identified pathways to synthesizing chiral building blocks for C1-symmetric, 
P-stereogenic ligands. A method to resolve the diastereomers of 3 will be needed to access the 
desired ligands. A later iteration of this synthesis method by Dr. Landers found that addition of 
HCl (1 equiv) in the initial step improved the result. Addition of a base to phosphine-borane 3 will 
deprotonate the PH unit yielding an anion which will readily accept an R group (like Mes*), 
followed by removal of the BH3 protecting group and finally coordination to a metal center. This 
approach is expected to afford highly customizable catalysts with a tunable binding pocket for 
asymmetric hydrogenation of problem substrates. Product 6 shows similar promise. A variety of 
building blocks is needed to afford the customizability necessary to build catalysts capable of 
selectively hydrogenating specific substrates.  
 Synthesis of product 10 demonstrates that (R)-BINOL can replace (-)-menthol in 
diastereoselectively generating a P-stereocenter. The diastereomers need to be resolved by 
recrystallization or chromatography. Addition of an acid such as HCl will protonate the sp2 
nitrogen or complexation of the phosphorous center with a soft acid such as Ag(I) or Cu(I) and 
may enhance crystallinity or separation.12 Stereoselective P-O cleavage is expected to afford a C1-
symmetric, P-stereogenic ligand via Approach 2. 
 Failure to achieve recrystallization in product 13 illustrates the importance of sufficient 
steric bulk in the selection of R groups to afford stability of the substituent by preventing 
oligomerization. In this regard, Mes* is generally successful and HMT occasionally works. These 
groups contain outer isopropyl and methyl substituents, respectively. This work has shown that 
addition of PCl2 to tricyclohexylbenzene produces the desired molecule without oligomerization, 
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but results in an oily product which we were not able to purify. It may still be possible to 
recrystallize 13 through the use of other solvents or another method. Addition of methyl or 
isopropyl substituents to the cyclohexyl rings would add steric bulk and may give a result more 
like the successful groups Mes* and HMT. More research is also needed to identify other possible 
sterically bulky R groups that will allow for both customizability and crystallinity in chiral ligand 
building blocks.  
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